DDI-DrugBank.d744.s0 >> Acromegalic patients with diabetes mellitus being treated with insulin and/or oral hypoglycemic agents may require dose reductions of these therapeutic agents after the initiation of therapy with SOMAVERT. >> 63-69,83-94,196-203
DDI-DrugBank.d744.s1 >> In clinical studies, patients on opioids often needed higher serum pegvisomant concentrations to achieve appropriate IGF-I suppression compared with patients not receiving opioids. >> 33-39,67-77,172-178
DDI-DrugBank.d744.s2 >> The mechanism of this interaction is not known.
